Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.37
-0.39 (-2.61%)
At close: Nov 12, 2026, 4:00 PM EST
14.37
0.00 (0.00%)
After-hours: Nov 12, 2026, 4:04 PM EST
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $615.05 million as of November 12, 2026. It is the 12,941st most valuable company in the world and the 2,565th biggest in the United States. Its market cap has increased by 139.61% in one year.
Market Cap
615.05M
Enterprise Value
444.90M
1-Year Change
139.61%
Global Rank
Country Rank
#2,565 United States
Category
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $615.05M, an increase of 99.18%. That is a compound annual growth rate of 63.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 595.79M | 156.96% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helus Pharma | 662.66M |
| Apnimed | 660.26M |
| Aclaris Therapeutics | 658.24M |
| Adlai Nortye Group | 641.40M |
| Olema Pharmaceuticals | 636.90M |
| Geron | 627.62M |
| Surrozen | 622.17M |
| Arbutus Biopharma | 585.58M |